MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Lobbying client · Texas · filed 2025 to 2026

$4,780,000 Reported spend

6 Filings counted

1 Firms hired

23 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (132410), not by name.

Firms hired 1

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) $4,780,000 6 filings

Bills named in these filings 23

HR 2484
Seniors’ Access to Critical Medications Act of 2025

6 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

5 filings
HR 2120
ROCR Value Based Program Act

5 filings
HR 2444
Promoting Resilient Supply Chains Act of 2025

5 filings
HR 3164
Ensuring Community Access to Pharmacist Services Act

5 filings
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025

5 filings
HR 3521
Clinical Trial Modernization Act

5 filings
HR 879
Medicare Patient Access and Practice Stabilization Act of 2025

5 filings
S 1816
Improving Seniors’ Timely Access to Care Act of 2025

5 filings
S 257
Promoting Resilient Supply Chains Act of 2025

5 filings
HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

4 filings
S 3822
Break Up Big Medicine Act

2 filings
HR 3173
Improving Seniors’ Timely Access to Care Act of 2022

1 filing
S 3018
Improving Seniors’ Timely Access to Care Act of 2021

1 filing
HR 2474
Strengthening Medicare for Patients and Providers Act

1 filing
HR 2630
Safe Step Act

1 filing
HR 3561
PATIENT Act of 2023

1 filing
HR 4473
Medicare Patient Access to Cancer Treatment Act

1 filing
HR 5376
Share the Savings with Seniors Act

1 filing
S 127
Pharmacy Benefit Manager Transparency Act of 2023

1 filing
S 1339
Pharmacy Benefit Manager Reform Act

1 filing
HR 4011
Community Paramedicine Act of 2025

1 filing
S 652
Protecting Patients from Deceptive Drug Ads Act

1 filing

Reported by year 2 years

2026 $1,390,000 2 filings
2025 $3,390,000 4 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Centers For Medicare and Medicaid Services (CMS) 5
White House Office 5
Office of Management & Budget (OMB) 1

Recent filings 7 total

Q2

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $530,000 expenses · posted Jul 20, 2026

View → Q1

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $860,000 expenses · posted Apr 20, 2026

View → Q4

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $1,180,000 expenses · posted Jan 19, 2026

View → Q3

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $530,000 expenses · posted Oct 20, 2025

View → Q2

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $460,000 expenses · posted Jul 17, 2025

View → 1A

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $1,220,000 expenses · posted Apr 24, 2025

View → Q1

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) Amended

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $1,220,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.